Related Experiment Video
Updated: Mar 29, 2026

Separation of Immune Cell Subpopulations in Peripheral Blood Samples from Children with Infectious Mononucleosis
Published on: September 7, 2022
Age-Dependent Hepatic Involvement in Pediatric Epstein-Barr Virus Infection: Clinical Associations and Biochemical
Tuğba Gürsoy Koca1, Dicle Şener Okur2, Abdülkerim Elmas3
1Department of Pediatrics, Division of Pediatric Gastroenterology, Hepatology and Nutrition, Pamukkale University Faculty of Medicine, Denizli 20070, Türkiye.
Insights
Epstein-Barr virus (EBV) infection commonly causes hepatitis in children, particularly older ones. Most cases resolve with supportive care, with typical recovery within 20 days.
Area of Science:
- Pediatric Infectious Diseases
- Hepatology
- Virology
Background:
- Epstein-Barr virus (EBV) is a common childhood infection often associated with liver enzyme abnormalities.
- Hepatic involvement in pediatric EBV infection is typically self-limited, but data on predictors and recovery are limited.
Purpose of the Study:
- To determine the frequency and severity of liver involvement in children with primary EBV infection.
- To identify clinical and laboratory predictors of hepatitis in pediatric EBV infection.
- To analyze biochemical recovery patterns in pediatric EBV hepatitis.
Main Methods:
- Retrospective cohort study of children (0-18 years) with confirmed primary EBV infection.
- Exclusion of co-infections, chronic liver disease, and hepatotoxic drug exposure.
- Definition of hepatic involvement as elevated ALT; logistic regression used to identify predictors.
Main Results:
- Hepatitis occurred in 59.2% of 294 pediatric EBV cases.
- Older age was an independent predictor of hepatitis (OR 1.010 per year increase, p < 0.001).
- Median time to ALT normalization was 20 days; no acute liver failure observed.
Conclusions:
- Hepatic involvement is frequent in pediatric EBV infection, with higher incidence in older children.
- Biochemical recovery is typical, and all patients experienced full recovery with supportive care.
- Understanding age-related risks and recovery patterns can optimize management and reduce unnecessary investigations.
Abstract:
Background: Epstein-Barr virus (EBV) infection is common in childhood and frequently accompanied by liver enzyme abnormalities. Although hepatic involvement is generally self-limited, pediatric data on predictors of hepatitis and biochemical recovery dynamics remain limited. This study aimed to evaluate the frequency and severity of hepatic involvement in children with primary EBV infection and identify clinical and laboratory features associated with hepatitis. Methods: This retrospective cohort study included children aged 0-18 years with serologically confirmed primary EBV infection at a tertiary center between January 2015 and November 2024. Patients with cytomegalovirus co-infection, hepatotropic viral infections, chronic liver disease, hepatotoxic drug exposure, or incomplete records were excluded. Demographic, clinical, and laboratory data were collected. Hepatic involvement was defined as ALT elevation above age-adjusted upper limits. Group comparisons utilized appropriate parametric and non-parametric tests, and logistic regression assessed predictors of hepatitis. Results: A total of 294 patients were included (median age: 6.1 years), of whom 48.6% were male. Hepatitis occurred in 59.2% of cases. Children with hepatitis were older than those without (median 6.7 vs. 5.3 years, p < 0.001). Logistic regression demonstrated that increasing age independently predicted hepatitis (odds ratio per year increase: 1.010; 95%CI 1.005-1.015; p < 0.001). Median time to ALT normalization was 20 days, and no patient developed acute liver failure. Conclusions: Hepatic involvement is common in pediatric EBV infection and is more frequent in older children. Despite significant biochemical abnormalities, all patients recovered fully with supportive care. Recognizing age-related risk and typical recovery patterns may reduce unnecessary investigations and guide appropriate management in pediatric EBV hepatitis.
More Related Videos
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Pharmacokinetics in Pediatric Patients: Drug Excretion
Pharmacokinetics in Pediatric Patients: Drug Distribution
Hepatitis
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

